W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Opinion of the President – health policy program for early diagnosis of neurodevelopmental disorders in the population of children aged 0-7 years in foster care in Lubuskie province

more...

Recommendation of the President – Citrulline 200, Citrulline 1000, L-Citrulline

more...

Tariff Council meeting 14/2024 on 31 October 2024 – update

more...

Opinion of the Transparency Council – nivolumab

more...

Communication of the meeting of Transparency Council No. 45/2024 on 28 October 2024

more...

Opinion of the Transparency Council – Program of newborn screening in the Republic of Poland for 2019-2026

more...

Position of the Transparency Council – Kaftrio (ivacaftor + tezacaftor + elexacaftor)

more...

Position of the Transparency Council – Kalydeco (ivacaftor)

more...

Position of the Transparency Council – Nucala (mepolizumab)

more...

Position of the Transparency Council – Trodelvy (sacituzumab govitecan)

more...

Position of the Transparency Council – Lonsurf (trifluridine + tipiracil)

more...

Opinion of the President – program of comprehensive therapy and rehabilitation of persons aged 0-25 from the City of Zabrze

more...

Opinion of the President – draft program to improve maternal and child care in the Opolskie Province from 2024 to 2026

more...

Opinion of the President – program for prevention of type 2 diabetes and cardiovascular diseases for residents of the municipality of Połczyn-Zdrój for 2025-2029

more...

Tariff Council meeting 14/2024 on 31 October 2024

more...

Recommendation of the President – free fetal DNA (cffDNA) testing for non-invasive prenatal diagnosis

more...

Recommendation of the President – Disulone (dapsoneum)

more...

The Transparency Council meeting 46/2024 on 4 November 2024

more...

Recommendation of the President – determination of placental growth factor (PlGF) in non-invasive prenatal diagnosis

more...

Opinion of the Transparency Council – on the appropriateness of making changes to the B.111 drug program

more...

Position of the Transparency Council – Elvanse

more...

Position of the Transparency Council – Opdivo (nivolumab)

more...

Communication of the meeting of Transparency Council No. 44/2024 on 21 October 2024

more...

Recommendation of the President – determination of estriol

more...